help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, J. Y.
Right arrow Articles by Kuo, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, J. Y.
Right arrow Articles by Kuo, M. T.

Endocrinology, Vol 133, 521-528, Copyright © 1993 by Endocrine Society

ARTICLES

Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells

JY Zhao, M Ikeguchi, T Eckersberg and MT Kuo
Department of Molecular Pathology, University of Texas M. D. Anderson Cancer Center, Houston 77030.

Considerable evidence has accumulated indicating that overexpression of P-glycoproteins encoded by the multidrug-resistance (mdr) genes is responsible for the development of collateral resistance to a number of structurally and functionally dissimilar cytotoxic compounds in animal cells. There are three mdr genes (mdr1, mdr2, and mdr3) in the mouse genome and two (MDR1 and MDR2) in the human genome; however, only two mouse genes (mdr1 and mdr3) and one human gene (MDR1) can confer multidrug resistance upon transfection into otherwise drug-sensitive cells. Using RNase protection assay we report here that the steady- state levels of mdr1 and mdr3 messenger RNA were elevated in mouse hepatoma cells treated with dexamethasone (Dex); whereas no induction of mdr2 gene was found. Western blot analyses using anti-mdr1 and anti- mdr3 antibodies revealed that the encoded proteins appeared to be increased, but at much reduced levels. The induction was time and Dex concentration dependent. Nuclear run-on experiments demonstrated that the induction was at least in part by transcriptional control. The induction apparently required new protein synthesis since no increases in mdr1 and mdr3 transcripts was found when cultured cells were simultaneously treated with Dex and cycloheximide. Neither mdr1 nor mdr3 gene was induced in the Dex-treated nonhepatoma cell lines, LMtk- and NIH3T3. Similarly, MDR1 messenger RNA levels were elevated in the Dex-treated human hepatoma line, HepG2, but not in the nonhepatoma, HeLa. This study demonstrated that the hormonal regulation of mdr gene expression is gene and cell type specific.


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
S. Lam, N. Partovi, L. S. Ting, and M. H. Ensom
Corticosteroid Interactions with Cyclosporine, Tacrolimus, Mycophenolate, and Sirolimus: Fact or Fiction?
Ann. Pharmacother., July 1, 2008; 42(7): 1037 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
B. Sarkadi, L. Homolya, G. Szakacs, and A. Varadi
Human Multidrug Resistance ABCB and ABCG Transporters: Participation in a Chemoimmunity Defense System.
Physiol Rev, October 1, 2006; 86(4): 1179 - 1236.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
N. Nishio, T. Katsura, K. Ashida, M. Okuda, and K.-i. Inui
MODULATION OF P-GLYCOPROTEIN EXPRESSION IN HYPERTHYROID RAT TISSUES
Drug Metab. Dispos., November 1, 2005; 33(11): 1584 - 1587.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
D. Anglicheau, M. Flamant, M. H. Schlageter, F. Martinez, B. Cassinat, P. Beaune, C. Legendre, and E. Thervet
Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation
Nephrol. Dial. Transplant., November 1, 2003; 18(11): 2409 - 2414.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
G-T Ho, F M Moodie, and J Satsangi
Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?
Gut, May 1, 2003; 52(5): 759 - 766.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
J. M. Brady, N. J. Cherrington, D. P. Hartley, S. C. Buist, N. Li, and C. D. Klaassen
Tissue Distribution and Chemical Induction of Multiple Drug Resistance Genes in Rats
Drug Metab. Dispos., July 1, 2002; 30(7): 838 - 844.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
R. Yumoto, T. Murakami, M. Sanemasa, R. Nasu, J. Nagai, and M. Takano
Pharmacokinetic Interaction of Cytochrome P450 3A-Related Compounds with Rhodamine 123, a P-Glycoprotein Substrate, in Rats Pretreated with Dexamethasone
Drug Metab. Dispos., February 1, 2001; 29(2): 145 - 151.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
J.-M. Pascussi, L. Drocourt, J.-M. Fabre, P. Maurel, and M.-J. Vilarem
Dexamethasone Induces Pregnane X Receptor and Retinoid X Receptor-alpha Expression in Human Hepatocytes: Synergistic Increase of CYP3A4 Induction by Pregnane X Receptor Activators
Mol. Pharmacol., August 1, 2000; 58(2): 361 - 372.
[Abstract] [Full Text]

Home page
 Pharmacol. Rev.Home page
J. H. Lin, M. Chiba, and T. A. Baillie
Is the Role of the Small Intestine in First-Pass Metabolism Overemphasized?
Pharmacol. Rev., June 1, 1999; 51(2): 135 - 158.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Geick, M. Eichelbaum, and O. Burk
Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin
J. Biol. Chem., April 27, 2001; 276(18): 14581 - 14587.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society